Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-07 Sale | 2024-10-07 8:55 pm | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director | 1,175,713 | $29.25 | $34,385,673 | 5,626,396 (Indirect Direct) | View |
| 2024-07-01 Purchase(A) | 2024-08-27 4:10 pm | ALUMIS INC. | ALMS | AKKARAJU SRINIVAS Director | 1,562,500 | $16 | $25,000,000 | 3,266,498 (Indirect) | View |
| 2024-05-30 Purchase | 2024-06-03 9:45 pm | CARGO Therapeutics Inc. | CRGX | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 294,000 | $17 | $4,998,000 | 4,415,689 (Indirect) | View |
| 2023-12-21 Purchase | 2023-12-26 5:24 pm | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 904,977 | $4.42 | $3,999,998 | 1,789,093 (Indirect Direct) | View |
| 2023-11-14 Purchase | 2023-11-16 7:39 pm | CARGO Therapeutics Inc. | CRGX | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 666,666 | $15 | $9,999,990 | 4,121,689 (Indirect) | View |
| 2023-10-16 Purchase | 2023-10-18 5:46 pm | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director 10% Owner | 2,189,781 | $6.85 | $15,000,000 | 6,788,609 (Indirect) | View |
| 2023-02-14 Purchase | 2023-02-16 4:54 pm | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 937,500 | $16 | $15,000,000 | 4,519,361 (Indirect) | View |
| 2022-05-27 Purchase | 2022-06-01 4:13 pm | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 570,000 | $14 | $7,980,000 | 5,161,888 (Indirect) | View |
| 2022-04-11 Purchase | 2022-04-13 7:40 pm | Graphite Bio Inc. | GRPH | Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 424,464 | $4.0782 | $1,731,068 | 8,497,067 (Indirect) | View |
| 2022-01-21 Purchase | 2022-01-25 2:30 pm | Graphite Bio Inc. | GRPH | Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 123,000 | $8.9358 | $1,099,100 | 8,072,603 (Indirect) | View |
| 2022-01-19 Purchase | 2022-01-21 1:48 pm | Graphite Bio Inc. | GRPH | Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 97,670 | $9.0988 | $888,677 | 7,949,603 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-16 Exercise | 2024-09-18 5:00 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 2,667 | $0 | 12,000 (Direct) | View |
| 2024-06-27 Option Award | 2024-07-01 5:13 pm | N/A 2034-06-27 | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director | 31,500 | $0 | 6,820,109 (Direct) | View |
| 2024-07-01 Conversion | 2024-07-01 4:40 pm | N/A N/A | ALUMIS INC. | ALMS | AKKARAJU SRINIVAS Director | 1,703,998 | $0 | 1,703,998 (Indirect) | View |
| 2024-07-01 Disposition | 2024-07-01 4:40 pm | N/A N/A | ALUMIS INC. | ALMS | AKKARAJU SRINIVAS Director | 1,703,998 | $0 | 1,703,998 (Indirect) | View |
| 2024-07-01 Option Award | 2024-07-01 4:40 pm | N/A N/A | ALUMIS INC. | ALMS | AKKARAJU SRINIVAS Director | 1,703,998 | $0 | 1,703,998 (Indirect) | View |
Ownership | 2024-06-27 4:09 pm | N/A N/A | ALUMIS INC. | ALMS | AKKARAJU SRINIVAS Director | 0 | $0 | 1,703,998 (Indirect) | View |
| 2024-02-27 Option Award | 2024-06-13 6:22 pm | N/A 2034-02-27 | vTv Therapeutics Inc. | VTVT | AKKARAJU SRINIVAS Director 10% Owner | 3,750 | $0 | 3,750 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:41 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 4,000 | $0 | 6,666 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:21 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 7:33 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | AKKARAJU SRINIVAS Director 10% Owner | 833,693 | $11.8 | 1,099,313 (Indirect) | View |
| 2024-02-27 Option Award | 2024-02-29 7:33 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | AKKARAJU SRINIVAS Director 10% Owner | 224,732 | $11.81 | 1,099,313 (Indirect) | View |
Ownership | 2024-02-29 7:31 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | AKKARAJU SRINIVAS Director 10% Owner | 0 | $0 | 40,888 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 9:07 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director 10% Owner | 555,555 | $13.5 | 5,074,916 (Indirect) | View |
| 2023-11-14 Conversion | 2023-11-16 7:39 pm | N/A N/A | CARGO Therapeutics Inc. | CRGX | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 6,762,646 | $0 | 4,121,689 (Indirect) | View |
| 2023-11-08 Disposition | 2023-11-13 2:51 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 8,111 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:51 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 678,575 | $19 | 0 (Direct) | View |
| 2023-11-08 Disposition | 2023-11-13 2:51 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 50,973 | $0 | 0 (Direct) | View |
Ownership | 2023-11-09 6:29 pm | N/A N/A | CARGO Therapeutics Inc. | CRGX | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 0 | $0 | 3,455,023 (Indirect) | View |
| 2023-09-16 Exercise | 2023-09-19 4:46 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 2,666 | $0 | 8,000 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:04 pm | N/A 2031-06-03 | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 5,948 | $23.19 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:04 pm | N/A 2032-05-25 | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 13,300 | $26.12 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:04 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 5,165,188 | $0 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:04 pm | N/A 2030-10-05 | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 23,522 | $25.23 | 0 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 6:48 pm | N/A 2033-06-21 | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:22 pm | N/A 2033-05-31 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-31 7:25 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 3,300 | $0 | 3,300 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:37 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 20,658 | $0 | 699,233 (Direct) | View |
| 2022-09-16 Option Award(A) | 2023-04-20 4:39 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 711,489 | $0 | 1,592,939 (Direct) | View |
| 2023-02-14 Conversion | 2023-02-16 4:54 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 7,163,722 | $0 | 4,519,361 (Indirect) | View |
| 2023-02-09 Option Award | 2023-02-13 9:02 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2023-02-09 7:52 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 0 | $0 | 3,581,861 (Indirect) | View |
| 2022-09-23 Other | 2022-09-23 6:39 pm | N/A N/A | Jiya Acquisition Corp. | JYAC | AKKARAJU SRINIVAS Jiya Holding Co LLC Director 10% Owner | 29,667 | $0 | 2,437,114 (Indirect) | View |
| 2022-09-16 Option Award | 2022-09-20 4:15 pm | N/A 2032-09-16 | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director | 56,000 | $0 | 56,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:07 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2022-07-28 5:02 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | AKKARAJU SRINIVAS Director | 0 | $0 | 5,663,632 (Indirect) | View |
| 2022-06-01 Option Award | 2022-06-02 7:10 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 6:04 pm | N/A 2032-05-25 | CHINOOK THERAPEUTICS INC. | KDNY | AKKARAJU SRINIVAS Director | 16,600 | $0 | 16,600 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 4:18 pm | N/A 2032-05-25 | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 20,527 | $0 | 691,365 (Direct) | View |